ENDENVO Trademark

Trademark Overview


On Friday, October 8, 2021, a trademark application was filed for ENDENVO with the United States Patent and Trademark Office. The USPTO has given the ENDENVO trademark a serial number of 97065499. The federal status of this trademark filing is REGISTERED as of Tuesday, November 29, 2022. This trademark is owned by Glaxo Group Limited. The ENDENVO trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
endenvo

General Information


Serial Number97065499
Word MarkENDENVO
Filing DateFriday, October 8, 2021
Status700 - REGISTERED
Status DateTuesday, November 29, 2022
Registration Number6910708
Registration DateTuesday, November 29, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, August 11, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 11, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 11, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 11, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 11, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 29, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 29, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 5, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 11, 2022EXAMINER'S AMENDMENT ENTERED
Monday, July 11, 2022ASSIGNED TO LIE
Sunday, July 10, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sunday, July 10, 2022EXAMINERS AMENDMENT E-MAILED
Sunday, July 10, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, July 7, 2022ASSIGNED TO EXAMINER
Monday, November 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 12, 2021NEW APPLICATION ENTERED